Related references
Note: Only part of the references are listed.Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for Gq/11 class G proteins
Matthew M. Meleka et al.
PHARMACOLOGICAL RESEARCH (2019)
Small molecules targeting heterotrimeric G proteins
Mohammed Akli Ayoub
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram et al.
MOLECULAR PHARMACOLOGY (2018)
Targeting G protein-coupled receptor signalling by blocking G proteins
Adrian P. Campbell et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR
Yiwei Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
G-protein inhibition profile of the reported Gq/11 inhibitor UBO-QIC
Jyrki P. Kukkonen
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin
Zhan-Guo Gao et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Atorvastatin inhibits CXCR7 induction to reduce macrophage migration
Wanshu Ma et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The ins and outs of pertussis toxin
Camille Locht et al.
FEBS JOURNAL (2011)
The P2Y2 Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells
Ling Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Arun K. Shukla et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule
Akiyuki Nishimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Biological properties of a specific Gαq/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress
Toshio Uemura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
I want a new drug: G-protein-coupled receptors in drug development
Sabune Schlyer et al.
DRUG DISCOVERY TODAY (2006)
Pharmacological properties of YM-254890, a specific Gαq/II inhibitor, on thrombosis and neointima formation in mice
T Kawasaki et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Novel mitogenic effect of adenosine on coronary artery smooth muscle cells -: Role for the A1 adenosine receptor
JZ Shen et al.
CIRCULATION RESEARCH (2005)
A novel Gαq/11-selective inhibitor
J Takasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The G protein-coupled receptor repertoires of human and mouse
DK Vassilatis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp QS3666
M Taniguchi et al.
JOURNAL OF ANTIBIOTICS (2003)
Share Paper
